Skip to main content
VCbacked
Log inGet Started

ILC Therapeutics

Newhouse, United Kingdom

ILC Therapeutics is an early-stage biotechnology company focused on modulating the Innate Immune System.

$3.3M raised
Sep 2024
Venture - Series Unknown
BiotechnologyHealth CareLife Science

Top Investors

Scottish EnterpriseMedical Incubator JapanEOS Technology Investment SyndicateRobert Kopple

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ILC Therapeutics

How much funding has ILC Therapeutics raised?
ILC Therapeutics has raised $3.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2024.
Who are ILC Therapeutics's investors?
ILC Therapeutics's investors include Scottish Enterprise, Medical Incubator Japan, EOS Technology Investment Syndicate, Robert Kopple.
Where is ILC Therapeutics headquartered?
ILC Therapeutics is headquartered in Newhouse, United Kingdom.
What does ILC Therapeutics do?
ILC Therapeutics is an early-stage biotechnology company focused on modulating the Innate Immune System.
What stage is ILC Therapeutics at?
ILC Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"ILC Therapeutics — Funding & Investors." VCBacked, September 11, 2024, https://www.vcbacked.co/company/ilc-therapeutics. Accessed July 1, 2026.
APA
VCBacked. (2024). ILC Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/ilc-therapeutics
Wikipedia (cite web)
{{cite web |title=ILC Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ilc-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver
Rapport Therapeutics
Boston
Neuroglee Therapeutics
Singapore
Living In Silico Inc.
Brampton
Navrogen
Philadelphia
MY01
Montréal